Binex Co

Binex Co Current Assets

The Current Assets of Binex Co (053030.KQ) as of Nov 3, 2026 is 40.02 B KRW. In the previous year, Current Assets was 90.73 B KRW — a change of -55.89% (lower).

Current Assets

40.02 BKRW

YoY

-55.89%

Last updated:

Current Assets of Binex Co is 2025 40.02 B KRW. Current Assets of Binex Co was 2024 90.73 B KRW. It decreases by -55.89% lower compared to the previous year.

The Binex Co Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
65.13 B KRW
Jan 1, 2019
87.52 B KRW
Jan 1, 2020
126.92 B KRW
Jan 1, 2021
121.33 B KRW
Jan 1, 2022
108.66 B KRW
Jan 1, 2023
71.61 B KRW
Jan 1, 2024
90.73 B KRW
Jan 1, 2025
40.02 B KRW
The Binex Co Current Assets history
YEARCurrent AssetsYoY
40.02 BKRW-55.89%
90.73 BKRW+26.69%
71.61 BKRW-34.09%
108.66 BKRW-10.44%
121.33 BKRW-4.40%
126.92 BKRW+45.02%
87.52 BKRW+34.37%
65.13 BKRW+19.20%
54.64 BKRW+13.31%
48.23 BKRW-10.40%
53.83 BKRW-3.59%
55.83 BKRW+107.40%
26.92 BKRW-18.62%
33.08 BKRW+27.72%
25.90 BKRW-40.65%
43.64 BKRW-21.72%
55.75 BKRW+138.96%
23.33 BKRW+1.15%
23.06 BKRW+5.26%
21.91 BKRW+10.40%
19.85 BKRW+25.06%
15.87 BKRW+46.22%
10.85 BKRW-0.21%
10.88 BKRW+16.90%
9.30 BKRW+12.76%
8.25 BKRW+21.37%
6.80 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Binex Co Stock analysis

What does Binex Co do? Binex Co Ltd generates revenue through the manufacturing and sale of pharmaceutical products including digestive system agents, circulatory system agents, ulcer agents, antacids, anti-inflammatory agents, analgesics, gastrointestinal tract regulators, antispasmodics, antiemetic drugs, antihistamines, laxatives, antihypertensive and urinary agents, antibacterial and antibiotic agents, cough and cold remedies, anti-diabetic medicines, ophthalmic solutions, vitamins, nutrients, and various ointments and creams. The company also produces bio medicines and raw materials. Binex Co Ltd distributes its products domestically within Busan and to overseas markets, targeting healthcare providers, pharmacies, and hospitals that purchase pharmaceuticals for patient care and treatment. The firm's product portfolio covers a wide range of therapeutic areas, including gastrointestinal health, cardiovascular support, pain management, respiratory care, and chronic disease management. By offering both branded and generic pharmaceutical solutions, Binex Co Ltd serves diverse customer segments across the domestic and international pharmaceutical markets, leveraging its manufacturing capabilities to meet regional healthcare demands. Binex Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Binex Co stock

Current Assets of Binex Co is 40.02 B KRW in 2025.

Current Assets of Binex Co changed from 90.73 B KRW to 40.02 B KRW, representing a -55.89% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Binex Co since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Binex Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Binex Co

All Key Metrics — Binex Co